000 | 03198nam a22005895i 4500 | ||
---|---|---|---|
001 | 978-3-031-46015-9 | ||
003 | DE-He213 | ||
005 | 20250516155934.0 | ||
007 | cr nn 008mamaa | ||
008 | 231201s2024 sz | s |||| 0|eng d | ||
020 |
_a9783031460159 _9978-3-031-46015-9 |
||
050 | 4 | _aRS400-431 | |
072 | 7 |
_aPSB _2bicssc |
|
072 | 7 |
_aSCI013040 _2bisacsh |
|
072 | 7 |
_aPNB _2thema |
|
082 | 0 | 4 |
_a615.19 _223 |
245 | 1 | 0 |
_a3D Printing _h[electronic resource] : _bEmerging Technologies and Functionality of Polymeric Excipients in Drug Product Development / _cedited by Michael A. Repka, Nigel Langley. |
250 | _a1st ed. 2024. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2024. |
|
300 |
_aXI, 288 p. 100 illus., 94 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aAAPS Advances in the Pharmaceutical Sciences Series, _x2210-738X ; _v44 |
|
505 | 0 | _aOverview of Pharmaceutical 3D Printing Technologies -- Clinical Benefit of 3D Printed Products -- Characterization or Quality Control of 3D Printed Products -- Polymers for HME based 3D Printing -- Cellulosic Polymers -- API and Polymer Selection Formulation and Process Variables -- Fused Deposition Modeling 3D Printing.-Semi-solid Extrusion Printing and 3D -- Future Trends Including Novel Polymeric Excipients Designed for Purpose Bioprinting. | |
520 | _aThis book is an educational text and guide for the use and properties of key polymeric excipients in the area of 3D printing in drug development. It is written by both industry experts and academic researchers. The particular focus is on hot melt extrusion and the extruded filaments suitable for optimizing the 3D printing in drug development. 3D Printing Polymeric Excipients, Technology, and Drug Formulation Development covers regulatory aspects as well as the manufacturing aspects. | ||
541 |
_fUABC ; _cPerpetuidad |
||
650 | 0 | _aPharmaceutical chemistry. | |
650 | 0 | _aPharmacology. | |
650 | 0 | _aBiotechnology. | |
650 | 0 |
_aBiology _xTechnique. |
|
650 | 1 | 4 | _aPharmaceutics. |
650 | 2 | 4 | _aPharmacology. |
650 | 2 | 4 | _aBiotechnology. |
650 | 2 | 4 | _aBiological Techniques. |
700 | 1 |
_aRepka, Michael A. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aLangley, Nigel. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer Nature eBook | |
776 | 0 | 8 |
_iPrinted edition: _z9783031460142 |
776 | 0 | 8 |
_iPrinted edition: _z9783031460166 |
776 | 0 | 8 |
_iPrinted edition: _z9783031460173 |
830 | 0 |
_aAAPS Advances in the Pharmaceutical Sciences Series, _x2210-738X ; _v44 |
|
856 | 4 | 0 |
_zLibro electrónico _uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-031-46015-9 |
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
942 | _cLIBRO_ELEC | ||
999 |
_c273715 _d273714 |